Skip to content


  • Erratum
  • Open Access

Erratum to: Safety of concurrent treatment of cats with fluralaner and emodepsid-praziquantel

  • 1Email author,
  • 2 and
  • 2
Parasites & Vectors20169:366

  • Received: 16 June 2016
  • Accepted: 16 June 2016
  • Published:

The original article was published in Parasites & Vectors 2016 9:322


Following publication of the original article [1], an error in the spelling of the active ingredient emodepside was noted. The correct spelling is emodepside and not emodepsid. This applies to the entire article, including the title.



Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Merck Animal Health, 2 Giralda Farms, Madison, NJ, USA
MSD Animal Health Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany


  1. Walther FM, Allan MJ, Roepke RKA. Safety of concurrent treatment of cats with fluralaner and emodepsid–praziquantel. Parasit Vectors. 2016;9:322. doi:10.1186/s13071-016-1618-y.View ArticlePubMedPubMed CentralGoogle Scholar


© The Author(s). 2016


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.